NorthWest Biotherapeutics Inc (NWBO)

[Lykiri]

Flipper,

Quote:
“Remember Dr. Bosch saying (for Direct that is) Method A was only partially potent whereas method B was more potent? I think you might hear the same exact comment from NWBO/UCLA with regard to before Germany, and after Germany. The publication likely to be critical, and now it dawns on me, because I only vaguely understand patent approvals, that Doc may be right there might have been more optimization than just TFF. Doc thinks it has something to do with cell selection chip technology developed by Fraunhofer. Anyway, if this whole hypothesis is correct, the publication would, imho, be very important for the patent office. JMHO. – flip”

Are you talking about the new microhole chip, developed by the Fraunhofer researchers (Fraunhofer Institute for Biomedical Engineering IBMT)?
And if so, do you have any idea how this new cell selection chip technology can be applied in the development of a more potent dcvax?

More about the new microhole chip: https://www.fraunhofer.de/en/press/research-news/2017/june/single-cells-lined-up-like-ducks-in-a-row.html